These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Ann Intern Med; 1999 Oct 19; 131(8):564-72. PubMed ID: 10523216 [Abstract] [Full Text] [Related]
3. Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Blood Press Monit; 2015 Apr 19; 20(2):57-63. PubMed ID: 25405819 [Abstract] [Full Text] [Related]
4. Target organ damage in "white coat hypertension" and "masked hypertension". Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G, Hatzitolios A, Rizos Z, Sion M, Zakopoulos N. Am J Hypertens; 2008 Apr 19; 21(4):393-9. PubMed ID: 18292757 [Abstract] [Full Text] [Related]
5. Untreated Masked Hypertension and Subclinical Cardiac Damage: A Systematic Review and Meta-analysis. Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Am J Hypertens; 2015 Jun 19; 28(6):806-13. PubMed ID: 25468808 [Abstract] [Full Text] [Related]
6. White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording Venetia Study. Palatini P, Dorigatti F, Roman E, Giovinazzo P, Piccolo D, De Venuto G, Mattarei M, Cozzutti E, Gregori S, Mormino P, Pessina AC. J Hypertens; 1998 Jul 19; 16(7):977-84. PubMed ID: 9794738 [Abstract] [Full Text] [Related]
9. Assessment of target-organ damage in adolescent white-coat and sustained hypertensives. Páll D, Juhász M, Lengyel S, Molnár C, Paragh G, Fülesdi B, Katona E. J Hypertens; 2010 Oct 19; 28(10):2139-44. PubMed ID: 20616755 [Abstract] [Full Text] [Related]
11. Left ventricular mass index in children with white coat hypertension. Lande MB, Meagher CC, Fisher SG, Belani P, Wang H, Rashid M. J Pediatr; 2008 Jul 19; 153(1):50-4. PubMed ID: 18571535 [Abstract] [Full Text] [Related]
12. The influence of white-coat hypertension on left atrial phasic function. Tadic M, Cuspidi C, Pencic B, Rihor B, Radojkovic J, Kocijanic V, Celic V. Blood Press; 2017 Apr 19; 26(2):102-108. PubMed ID: 27599391 [Abstract] [Full Text] [Related]
14. Target organ status in white-coat hypertensives: usefulness of serum procollagen type I propeptide in the respect of left ventricular diastolic dysfunction. Ihm SH, Youn HJ, Park CS, Kim HY, Chang K, Seung KB, Kim JH, Choi KB. Circ J; 2009 Jan 19; 73(1):100-5. PubMed ID: 19023153 [Abstract] [Full Text] [Related]
15. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Mancia G, Bombelli M, Brambilla G, Facchetti R, Sega R, Toso E, Grassi G. Hypertension; 2013 Jul 19; 62(1):168-74. PubMed ID: 23716584 [Abstract] [Full Text] [Related]
17. Relationship between insulin resistance and end-organ damage in white coat hypertension. Tunçkale A, Aran SN, Karpuz H, Dirican A. Am J Hypertens; 2004 Nov 19; 17(11 Pt 1):1011-6. PubMed ID: 15533726 [Abstract] [Full Text] [Related]